Dosed ingredient Cosmetic cross-reference

Magnesium Carbonate

CAS 546-93-0

Magnesium Carbonate (CAS 546-93-0) is a Phase 4 pharmaceutical compound with 0 bioactivity targets and 58 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
0
SOURCE DrugCentral
Adverse signals
58
SOURCE IUPHAR/BPS
PubMed IDs
0
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
Magnesium Carbonate
CAS Number
546-93-0
UNII
0IHC698356
InChIKey
ZLNQQNXFFQJAID-UHFFFAOYSA-L
ChEMBL ID
CHEMBL1200736
Molecule Type
Small molecule
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
dosed ingredient
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 4 (Approved)
Approved or marketed human pharmaceutical use is represented in the source phase field.
ChEMBL CHEMBL1200736 | Small molecule
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →
SOURCE DrugCentral 58 associations

Adverse Event Associations

DrugCentral / FAERS disproportionality signal rows matched to this compound.

Reaction PTDrug AE LLRMedDRA
Vaginal flatulence 22 71.022 10064227
Appendicolith 27 68.848 10074458
Blood phosphorus increased 28 65.649 10050196
Proctitis 23 55.487 10036774
Female genital tract fistula 22 54.263 10061149
Hyponatraemia 76 51.586 10021036
Appendicitis 30 50.809 10003011
Vaginal discharge 22 50.239 10046901
Radiculopathy 23 48.605 10037779
Mesothelioma 10 42.364 10027406
Chronic sinusitis 23 41.25 10009137
Blood uric acid increased 22 39.422 10005861
Myasthenia gravis 20 39.134 10028417
Ventricular fibrillation 29 37.933 10047290
Macular degeneration 26 35.933 10025409
Cardiogenic shock 31 35.707 10007625
Abdominal pain 108 35.456 10000081
Paraesthesia oral 24 35.306 10057372
Vomiting 154 31.985 10047700
Procedural pain 23 30.897 10064882
Colitis 39 30.73 10009887
Colitis ulcerative 28 30.33 10009900
Oral candidiasis 25 29.544 10030963
Abdominal distension 50 29.39 10000060
Dyspepsia 49 29.166 10013946
Violence-related symptom 8 27.617 10047426
Epilepsy 28 27.585 10015037
Hepatic cytolysis 22 26.894 10049199
Frequent bowel movements 24 26.431 10017367
Dry mouth 40 24.762 10013781
Eyelid ptosis congenital 5 23.633 10015996
Glomerular filtration rate 5 23.334 10018355
Incorrect route of product administration 25 23.228 10081202
Fatigue 53 22.9 10016256
Drug ineffective 71 22.841 10013709
Analgesic therapy 7 22.777 10053469
Sleep disorder therapy 7 22.634 10040990
Drug therapy 7 21.519 10063370
Anaemia 101 21.082 10002034
Hyperphosphataemia 11 20.772 10020711
General physical health deterioration 72 20.753 10049438
Somnolence 67 20.391 10041349
Morbid thoughts 6 19.609 10050464
IVth nerve paresis 3 19.609 10054201
Stress 33 18.892 10042209
Caesarean section 15 18.659 10006924
Multiple organ dysfunction syndrome 39 18.065 10077361
Maternal drugs affecting foetus 12 17.587 10026923
Exposure during pregnancy 45 16.541 10073513
Scrotal oedema 6 15.544 10039755

Association rows are source-linked signal records, not incidence rates or clinical causality claims.

SOURCE NLM RxNorm 4 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

NameRxCUI TypeSource
MAGNESIUM CARBONATE 29155 SU MTHSPL
Magnesium Carbonate 29155 SU MTHSPL
magnesium carbonate 29155 SU MTHSPL
magnesium carbonate 29155 IN RXNORM
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Magnesium Carbonate used for in pharmaceutical contexts?

Magnesium Carbonate (CAS 546-93-0) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Magnesium Carbonate?

Magnesium Carbonate has 58 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Vaginal flatulence, Appendicolith, Blood phosphorus increased, Proctitis, Female genital tract fistula. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Magnesium Carbonate also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Magnesium Carbonate with EU status "permitted".

What clinical phase is Magnesium Carbonate in?

Magnesium Carbonate is rendered with ChEMBL max phase 4 (approved).